Perspective Therapeutics, Inc. ("Perspective" or the "Company") (NYSE AMERICAN: CATX), a radiopharmaceutical company that is pioneering advanced treatment applications for cancers throughout the body, ...

During the 43rd J.P. Morgan Annual Healthcare Conference last month, Areteia Therapeutics took centre stage, presenting a ...

The fallout from the F.D.A.’s rejection of MDMA-assisted treatment for PTSD worries researchers and experts who fear other ...

The understanding of the pathophysiology of atherosclerosis and related vascular diseases has changed over the last decade, providing new perspectives for preventive and therapeutic strategies.

Tyler James Williams told Deadline he's thought about directing since he was a child actor on Everybody Hates Chris ...

Cite this: Scabies: Molecular Perspectives and Therapeutic Implications in the Face of Emerging Drug Resistance - Medscape - Feb 01, 2008. Kate E. Mounsey, Charles Darwin University, Menzies ...

The root of the U.S.’s high prescription drug prices lies in its unique system, which allows pharmaceutical manufacturers to ...

announcing at the JP Morgan Healthcare conference this week that it had paid $28 million for a near-20% stake in Perspective Therapeutics and secured an option to license its Pb212-VMT-α-NET ...

The exploration of natural products and their structural analogues in neuropsychiatry has historically been a fertile area of research, driven by the ...

Plane accidents such as the collision above Reagan National Airport can trigger aerophobia, the fear of flying. Here’s how to ...

Recombinant antibodies are invented antibodies formed by using recombinant DNA technology. While traditional monoclonal ...

Jamie Boland died in June last year aged 38 after battling ketamine addiction and now his parents have called for the drug to ...